Beauty Health (NASDAQ:SKIN) Trading 3.1% Higher – What’s Next?

The Beauty Health Company (NASDAQ:SKIN) was up 3.1% during trading on Thursday . The company traded as high as $1.68 and last traded at $1.67. Approximately 250,190 shares changed hands during mid-day trading, a decline of 51% from the average daily volume of 506,165 shares. The stock had previously closed at $1.62.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group raised their target price on Beauty Health from $1.25 to $1.75 and gave the stock a “hold” rating in a research report on Wednesday, November 13th. One analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $2.55.

Beauty Health Stock Up 3.1 %

The company has a market capitalization of $207.28 million, a price-to-earnings ratio of -3.98 and a beta of 0.82. The business has a fifty day simple moving average of $1.61 and a two-hundred day simple moving average of $1.58. The company has a quick ratio of 5.57, a current ratio of 6.56 and a debt-to-equity ratio of 9.23.

Hedge Funds Weigh In On Beauty Health

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Raymond James Financial Inc. acquired a new position in Beauty Health during the fourth quarter worth $25,000. SG Americas Securities LLC bought a new stake in shares of Beauty Health in the 3rd quarter worth about $37,000. Sanctuary Advisors LLC acquired a new stake in shares of Beauty Health during the 2nd quarter worth about $47,000. Pilgrim Partners Asia Pte Ltd bought a new position in Beauty Health during the 4th quarter valued at about $57,000. Finally, Renaissance Technologies LLC acquired a new position in Beauty Health in the fourth quarter valued at about $64,000. Institutional investors own 93.26% of the company’s stock.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.